DrugPatentWatch Database Preview
Drugs in Development Information for Diphencyprone
» See Plans and Pricing
What is the development status for investigational drug Diphencyprone?
Diphencyprone is an investigational drug.
There have been 4 clinical trials for Diphencyprone.
The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2012.
The most common disease conditions in clinical trials are Hypersensitivity, Delayed, Hypersensitivity, and Dermatitis. The leading clinical trial sponsors are Innovaderm Research Inc., Brickell Biotech, Inc., and Rockefeller University.
There are eighty-eight US patents protecting this investigational drug and six hundred and seventy-seven international patents.
Summary for Diphencyprone
| US Patents | 88 |
| International Patents | 677 |
| US Patent Applications | 142 |
| WIPO Patent Applications | 228 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2012-10-01) |
| Vendors | 73 |
Recent Clinical Trials for Diphencyprone
| Title | Sponsor | Phase |
|---|---|---|
| Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers | Innovaderm Research Inc. | N/A |
| Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis | Brickell Biotech, Inc. | Phase 1 |
| Effect of RANKL Inhibition on UV-induced Immunosuppression | Innovaderm Research Inc. | Phase 1 |
Clinical Trial Summary for Diphencyprone
Top disease conditions for Diphencyprone
Top clinical trial sponsors for Diphencyprone
US Patents for Diphencyprone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Diphencyprone | Start Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | Start Trial |
| Diphencyprone | Start Trial | Topical compositions and methods for making and using same | SEBELA INTERNATIONAL BERMUDA LIMITED (Hamilton, BM) | Start Trial |
| Diphencyprone | Start Trial | Topical compositions and methods for making and using same | SEBELA INTERNATIONAL BERMUDA LIMITED (Hamilton, BM) | Start Trial |
| Diphencyprone | Start Trial | Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection | Squarex, LLC (Pine Springs, MN) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Diphencyprone
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Diphencyprone | Australia | AU2017261372 | 2036-05-05 | Start Trial |
| Diphencyprone | Canada | CA3023278 | 2036-05-05 | Start Trial |
| Diphencyprone | China | CN107847398 | 2036-05-05 | Start Trial |
| Diphencyprone | European Patent Office | EP3452003 | 2036-05-05 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
